Overcoming quinolone resistance in tuberculosis

Quinolone antibacterials currently are second-line treatment for tuberculosis and are used extensively when patients become resistant to or are intolerant of first-line treatment. Unfortunately, quinolone resistance is becoming prevalent. We are working with M. tuberculosis, gyrase, the target of quinolone antibacterials to define mechanisms that can be used to overcome drug resistance. 

Neil Osheroff [Email]
Department of Biochemistry

Nashville with the eventual possibility of Tres Cantos, Spain

Contacts N/A
Program Type


Funding Type

Scholarships, Fellowships, Internships, Grants


Africa, Asia

Global Health Topics

Basic Sciences, Infectious Diseases


Graduate students (non-clinical); Medical students (MD); Post-doctoral students, residents, or trainees

Program Length

Flexible, depending on the individuals interests and needs

VU Affiliation

The program is affiliated with Vanderbilt.


The program does not have a language requirement.